Skip to main content
  • Liver cancer therapies

    4th Annual Liver Cancer Therapies Conference

    December 6, 2024, 9 am - 4 pm | University of Maryland School of Medicine, Baltimore, MD

Liver Cancer Therapies 2024

Who Should Attend

This meeting will be of interest to Surgeons, Hepatologists, Oncologists, Interventional Radiologists, Gastoenterologists, Nurses, Nurse Practitioners, Physician Assistants, Residents, Fellows, and Medical Students.

Learning Objectives

  1. Discuss the scope of liver cancer program at UMMC and affiliated hospitals.
  2. Describe key directions in current liver cancer research.
  3. Identify new directions in treatments for liver cancer.

Conference Agenda & Faculty

The 2024 agenda is in development and will be available soon. Feel free to check out last year's agenda:

2023 Conference Agenda


We anticipate registration to open in the summer.

Accreditation and Credit Designation


The University of Maryland School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


The University of Maryland School of Medicine designates this Live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Questions

Gloria Owens
Academic Services Specialist
Office of Faculty Affairs and Professional Development
410-706-3103 fax

Liver Cancer Therapies 2024

December 6, 2024
Conference | 9 AM - 4 PM

UM School of Medicine
685 W. Baltimore St.,
Baltimore, MD 21201

Conference Co-Directors

Click a name to see the faculty profile.

Kevin KimKevin Kim, MD, MHS

Professor of Radiology & Medicine;
Chief, Div. of Vascular & Interventional Radiology & Oncology, UMGCCC

Daniel MalufDaniel G. Maluf, MD

Professor of Surgery;
Director, Program in Transplantation

Organizing Committee

Kirti Shetty, MDKirti Shetty, MD

Professor of Medicine;
Director, Section of Hepatology - Div. of GI & Hepatology;
Director of General & Transplant Hepatology

Chandra Bhati, MDChandra Bhati, MD

Professor of Surgery;
Chief, Division of Transplant Surgery
Surgical Director, Liver Transplantation

Yixing Jiang, MD, PhDYixing Jiang, MD, PhD

Professor of Medicine;
Director, GI Medical Oncology

Presented By:

Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC)

University of Maryland Transplant Center